Cargando…
Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model
The global prevalence of nonalcoholic fatty liver disease (NAFLD) is estimated to be 25% and has continued to increase; however, no drugs have yet been approved for NAFLD treatments. The ethyl acetate fraction of Amomum xanthioides (EFAX) was previously reported to have an anti-hepatic fibrosis effe...
Autores principales: | Im, Hwi-Jin, Hwang, Seung-Ju, Lee, Jin-Seok, Lee, Sung-Bae, Kang, Ji-Yun, Son, Chang-Gue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468949/ https://www.ncbi.nlm.nih.gov/pubmed/32823613 http://dx.doi.org/10.3390/nu12082433 |
Ejemplares similares
-
Ethyl Acetate Fraction of Amomum xanthioides Exerts Antihepatofibrotic Actions via the Regulation of Fibrogenic Cytokines in a Dimethylnitrosamine-Induced Rat Model
por: Lee, Sung-Bae, et al.
Publicado: (2016) -
Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines
por: Kim, Hyeong-Geug, et al.
Publicado: (2015) -
Ethyl Acetate Fraction of Amomum villosum var. xanthioides Attenuates Hepatic Endoplasmic Reticulum Stress-Induced Non-Alcoholic Steatohepatitis via Improvement of Antioxidant Capacities
por: Cho, Jung-Hyo, et al.
Publicado: (2021) -
Bacillus subtilis-Fermented Amomum xanthioides Ameliorates Metabolic-Syndrome-Like Pathological Conditions in Long-Term HFHFD-Fed Mice
por: Wang, Jing-Hua, et al.
Publicado: (2022) -
Insight into the phytochemical profile and antimicrobial activities of Amomum subulatum and Amomum xanthioides: an in vitro and in silico study
por: Alruhaili, Mohammed H., et al.
Publicado: (2023)